首页 > 最新文献

Journal of Biomedical Research最新文献

英文 中文
Exposure to lead and dietary furan intake aggravates hypothalamus-pituitary-testicular axis toxicity in chronic experimental rats. 暴露于铅和膳食呋喃的摄入加重慢性实验大鼠下丘脑-垂体-睾丸轴毒性。
IF 2.3 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-09-28 DOI: 10.7555/JBR.36.20220108
Solomon E Owumi, Uche O Arunsi, Moses T Otunla, Imisioluwa O Oluwasuji

Lead (Pb) and furan are toxic agents, and persistent exposure may impair human and animal reproductive function. We therefore explored the effects of Pb and furan on male rat hypothalamic-pituitary-gonadal reproductive status, oxidative stress, inflammation, and genomic integrity. We found that co-exposure to Pb and furan reduced the activities of testicular function enzymes, endogenous antioxidant levels, total sulfhydryl group, and glutathione. Sperm abnormality, biomarkers of oxidative stress, inflammation, and p53 expression were increased in a dose-dependent manner by treatment with furan and Pb. Typical rat gonad histoarchitecture features were also damaged. Conclusively, co-exposure to Pb and furan induced male reproductive function derangement by decreasing the antioxidant defences in rats, increasing abnormalities in spermatozoa morphology, and reducing reproductive hormone in circulation. These pathophysiological alterations, if persistent, might provide a permissive environment for potentiating reproductive dysfunction and infertility.

铅(Pb)和呋喃是有毒物质,持续接触可能损害人和动物的生殖功能。因此,我们探讨了铅和呋喃对雄性大鼠下丘脑-垂体-性腺生殖状态、氧化应激、炎症和基因组完整性的影响。我们发现,铅和呋喃的共同暴露降低了睾丸功能酶的活性、内源性抗氧化水平、总巯基和谷胱甘肽。用呋喃和铅处理后,精子异常、氧化应激、炎症和p53的生物标志物呈剂量依赖性增加。典型的大鼠性腺组织结构特征也被破坏。综上所述,铅和呋喃的共同暴露通过降低大鼠的抗氧化防御能力、增加精子形态异常和降低生殖激素循环来诱导雄性生殖功能紊乱。这些病理生理改变,如果持续,可能为增强生殖功能障碍和不孕症提供一个宽松的环境。
{"title":"Exposure to lead and dietary furan intake aggravates hypothalamus-pituitary-testicular axis toxicity in chronic experimental rats.","authors":"Solomon E Owumi,&nbsp;Uche O Arunsi,&nbsp;Moses T Otunla,&nbsp;Imisioluwa O Oluwasuji","doi":"10.7555/JBR.36.20220108","DOIUrl":"https://doi.org/10.7555/JBR.36.20220108","url":null,"abstract":"<p><p>Lead (Pb) and furan are toxic agents, and persistent exposure may impair human and animal reproductive function. We therefore explored the effects of Pb and furan on male rat hypothalamic-pituitary-gonadal reproductive status, oxidative stress, inflammation, and genomic integrity. We found that co-exposure to Pb and furan reduced the activities of testicular function enzymes, endogenous antioxidant levels, total sulfhydryl group, and glutathione. Sperm abnormality, biomarkers of oxidative stress, inflammation, and p53 expression were increased in a dose-dependent manner by treatment with furan and Pb. Typical rat gonad histoarchitecture features were also damaged. Conclusively, co-exposure to Pb and furan induced male reproductive function derangement by decreasing the antioxidant defences in rats, increasing abnormalities in spermatozoa morphology, and reducing reproductive hormone in circulation. These pathophysiological alterations, if persistent, might provide a permissive environment for potentiating reproductive dysfunction and infertility.</p>","PeriodicalId":15061,"journal":{"name":"Journal of Biomedical Research","volume":"37 2","pages":"100-114"},"PeriodicalIF":2.3,"publicationDate":"2022-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9517376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Peripheral CD4 +CD8 + double positive T cells: A potential marker to evaluate renal impairment susceptibility during systemic lupus erythematosus. 外周 CD4 +CD8 + 双阳性 T 细胞:评估系统性红斑狼疮肾功能损害易感性的潜在标志物。
IF 2.3 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-09-28 DOI: 10.7555/JBR.36.20220094
Kai Chang, Wanlin Na, Chenxia Liu, Hongxuan Xu, Yuan Liu, Yanyan Wang, Zhongyong Jiang

Lupus nephritis (LN) has a high incidence in systemic lupus erythematosus (SLE) patients, but there is a lack of sensitive predictive markers. The purpose of the study was to investigate the association between the CD4 +CD8 + double positive T (DPT) lymphocytes and LN. The study included patients with SLE without renal impairment (SLE-NRI), LN, nephritic syndrome (NS), or nephritis. Peripheral blood lymphocyte subsets were analyzed by flow cytometry. Biochemical measurements were performed with peripheral blood in accordance with the recommendations proposed by the National Center for Clinical Laboratories. The proportions of DPT cells in the LN group were significantly higher than that in the SLE-NRI group ( t=4.012, P<0.001), NS group ( t=3.240, P=0.001), and nephritis group ( t=2.57, P=0.011). In the LN group, the risk of renal impairment increased significantly in a DPT cells proportion-dependent manner. The risk of LN was 5.136 times (95% confidence interval, 2.115-12.473) higher in cases with a high proportion of DPT cells than those whose proportion of DPT cells within the normal range. These findings indicated that the proportion of DPT cells could be a potential marker to evaluate LN susceptibility, and the interference of NS and nephritis could be effectively excluded when assessing the risk of renal impairment during SLE with DPT cell proportion.

狼疮性肾炎(LN)在系统性红斑狼疮(SLE)患者中发病率很高,但却缺乏敏感的预测标志物。本研究旨在探讨 CD4 +CD8 + 双阳性 T(DPT)淋巴细胞与 LN 之间的关联。研究对象包括无肾功能损害的系统性红斑狼疮(SLE-NRI)、LN、肾炎综合征(NS)或肾炎患者。外周血淋巴细胞亚群通过流式细胞术进行分析。根据美国国家临床实验室中心(National Center for Clinical Laboratories)的建议对外周血进行生化测定。LN组的DPT细胞比例明显高于SLE-NRI组(t=4.012,Pt=3.240,P=0.001)和肾炎组(t=2.57,P=0.011)。在 LN 组中,肾功能损害的风险以 DPT 细胞比例依赖的方式显著增加。DPT细胞比例高的病例发生LN的风险是DPT细胞比例在正常范围内的病例的5.136倍(95%置信区间,2.115-12.473)。这些研究结果表明,DPT细胞比例可作为评估LN易感性的潜在标志物,在用DPT细胞比例评估系统性红斑狼疮肾功能损害风险时,可有效排除NS和肾炎的干扰。
{"title":"Peripheral CD4 <sup>+</sup>CD8 <sup>+</sup> double positive T cells: A potential marker to evaluate renal impairment susceptibility during systemic lupus erythematosus.","authors":"Kai Chang, Wanlin Na, Chenxia Liu, Hongxuan Xu, Yuan Liu, Yanyan Wang, Zhongyong Jiang","doi":"10.7555/JBR.36.20220094","DOIUrl":"10.7555/JBR.36.20220094","url":null,"abstract":"<p><p>Lupus nephritis (LN) has a high incidence in systemic lupus erythematosus (SLE) patients, but there is a lack of sensitive predictive markers. The purpose of the study was to investigate the association between the CD4 <sup>+</sup>CD8 <sup>+</sup> double positive T (DPT) lymphocytes and LN. The study included patients with SLE without renal impairment (SLE-NRI), LN, nephritic syndrome (NS), or nephritis. Peripheral blood lymphocyte subsets were analyzed by flow cytometry. Biochemical measurements were performed with peripheral blood in accordance with the recommendations proposed by the National Center for Clinical Laboratories. The proportions of DPT cells in the LN group were significantly higher than that in the SLE-NRI group ( <i>t</i>=4.012, <i>P</i><0.001), NS group ( <i>t</i>=3.240, <i>P</i>=0.001), and nephritis group ( <i>t</i>=2.57, <i>P</i>=0.011). In the LN group, the risk of renal impairment increased significantly in a DPT cells proportion-dependent manner. The risk of LN was 5.136 times (95% confidence interval, 2.115-12.473) higher in cases with a high proportion of DPT cells than those whose proportion of DPT cells within the normal range. These findings indicated that the proportion of DPT cells could be a potential marker to evaluate LN susceptibility, and the interference of NS and nephritis could be effectively excluded when assessing the risk of renal impairment during SLE with DPT cell proportion.</p>","PeriodicalId":15061,"journal":{"name":"Journal of Biomedical Research","volume":" ","pages":"59-68"},"PeriodicalIF":2.3,"publicationDate":"2022-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10680286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of mitophagy in the hallmarks of aging. 线粒体自噬在衰老标志中的作用。
IF 2.3 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-08-28 DOI: 10.7555/JBR.36.20220045
Jie Wen, Tingyu Pan, Hongyan Li, Haixia Fan, Jinhua Liu, Zhiyou Cai, Bin Zhao

Aging, subjected to scientific scrutiny, is extensively defined as a time-dependent decline in functions that involves the majority of organisms. The time-dependent accretion of cellular lesions is generally a universal trigger of aging, while mitochondrial dysfunction is a sign of aging. Dysfunctional mitochondria are identified and removed by mitophagy, a selective form of macroautophagy. Increased mitochondrial damage resulting from reduced biogenesis and clearance may promote the aging process. The primary purpose of this paper is to illustrate in detail the effects of mitophagy on aging and emphasize the associations between mitophagy and other signs of aging, including dietary restriction, telomere shortening, epigenetic alterations, and protein imbalance. The evidence regarding the effects of these elements on aging is still limited. And although the understanding of relationship between mitophagy and aging has been long-awaited, to analyze details of such a relationship remains the main challenge in aging studies.

经过科学的仔细研究,衰老被广泛地定义为涉及大多数生物体的功能随时间的下降。细胞病变的时间依赖性增加通常是衰老的普遍触发因素,而线粒体功能障碍是衰老的标志。功能失调的线粒体通过线粒体自噬(一种选择性的巨噬)被识别和去除。生物生成和清除减少导致的线粒体损伤增加可能会促进衰老过程。本文的主要目的是详细说明线粒体自噬对衰老的影响,并强调线粒体自噬与其他衰老迹象之间的关系,包括饮食限制、端粒缩短、表观遗传改变和蛋白质失衡。关于这些元素对衰老的影响的证据仍然有限。尽管人们对线粒体自噬与衰老之间关系的理解已经期待已久,但分析这种关系的细节仍然是衰老研究的主要挑战。
{"title":"Role of mitophagy in the hallmarks of aging.","authors":"Jie Wen,&nbsp;Tingyu Pan,&nbsp;Hongyan Li,&nbsp;Haixia Fan,&nbsp;Jinhua Liu,&nbsp;Zhiyou Cai,&nbsp;Bin Zhao","doi":"10.7555/JBR.36.20220045","DOIUrl":"https://doi.org/10.7555/JBR.36.20220045","url":null,"abstract":"<p><p>Aging, subjected to scientific scrutiny, is extensively defined as a time-dependent decline in functions that involves the majority of organisms. The time-dependent accretion of cellular lesions is generally a universal trigger of aging, while mitochondrial dysfunction is a sign of aging. Dysfunctional mitochondria are identified and removed by mitophagy, a selective form of macroautophagy. Increased mitochondrial damage resulting from reduced biogenesis and clearance may promote the aging process. The primary purpose of this paper is to illustrate in detail the effects of mitophagy on aging and emphasize the associations between mitophagy and other signs of aging, including dietary restriction, telomere shortening, epigenetic alterations, and protein imbalance. The evidence regarding the effects of these elements on aging is still limited. And although the understanding of relationship between mitophagy and aging has been long-awaited, to analyze details of such a relationship remains the main challenge in aging studies.</p>","PeriodicalId":15061,"journal":{"name":"Journal of Biomedical Research","volume":"37 1","pages":"1-14"},"PeriodicalIF":2.3,"publicationDate":"2022-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898045/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9236354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pyroptosis is a drug target for prevention of adverse cardiac remodeling: The crosstalk between pyroptosis, apoptosis, and autophagy. 焦亡是预防不良心脏重构的药物靶点:焦亡、细胞凋亡和自噬之间的串扰。
IF 2.3 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-08-10 DOI: 10.7555/JBR.36.20220123
Natalia V Naryzhnaya, Leonid N Maslov, Sergey V Popov, Alexandr V Mukhomezyanov, Vyacheslav V Ryabov, Boris K Kurbatov, Alexandra E Gombozhapova, Nirmal Singh, Feng Fu, Jian-Ming Pei, Sergey V Logvinov

Acute myocardial infarction (AMI) is one of the main reasons of cardiovascular disease-related death. The introduction of percutaneous coronary intervention to clinical practice dramatically decreased the mortality rate in AMI. Adverse cardiac remodeling is a serious problem in cardiology. An increase in the effectiveness of AMI treatment and prevention of adverse cardiac remodeling is difficult to achieve without understanding the mechanisms of reperfusion cardiac injury and cardiac remodeling. Inhibition of pyroptosis prevents the development of postinfarction and pressure overload-induced cardiac remodeling, and mitigates cardiomyopathy induced by diabetes and metabolic syndrome. Therefore, it is reasonable to hypothesize that the pyroptosis inhibitors may find a role in clinical practice for treatment of AMI and prevention of cardiac remodeling, diabetes and metabolic syndrome-triggered cardiomyopathy. It was demonstrated that pyroptosis interacts closely with apoptosis and autophagy. Pyroptosis could be inhibited by nucleotide-binding oligomerization domain-like receptor with a pyrin domain 3 inhibitors, caspase-1 inhibitors, microRNA, angiotensin-converting enzyme inhibitors, angiotensin Ⅱ receptor blockers, and traditional Chinese herbal medicines.

急性心肌梗死(AMI)是心血管疾病相关死亡的主要原因之一。经皮冠状动脉介入治疗的临床应用显著降低了急性心肌梗死的死亡率。不良心脏重构是心脏病学中的一个严重问题。如果不了解心脏再灌注损伤和心脏重构的机制,就很难提高AMI治疗的有效性和预防不良心脏重构。抑制焦亡可防止梗死后的发展和压力超载引起的心脏重构,减轻糖尿病和代谢综合征引起的心肌病。因此,我们有理由推测焦亡抑制剂可能在治疗AMI、预防心脏重构、糖尿病和代谢综合征引发的心肌病等方面发挥临床作用。研究表明,焦亡与细胞凋亡和自噬密切相关。核苷结合寡聚结构域样受体与pyrin结构域3抑制剂、caspase-1抑制剂、microRNA、血管紧张素转换酶抑制剂、血管紧张素Ⅱ受体阻滞剂和传统中草药均可抑制焦死。
{"title":"Pyroptosis is a drug target for prevention of adverse cardiac remodeling: The crosstalk between pyroptosis, apoptosis, and autophagy.","authors":"Natalia V Naryzhnaya,&nbsp;Leonid N Maslov,&nbsp;Sergey V Popov,&nbsp;Alexandr V Mukhomezyanov,&nbsp;Vyacheslav V Ryabov,&nbsp;Boris K Kurbatov,&nbsp;Alexandra E Gombozhapova,&nbsp;Nirmal Singh,&nbsp;Feng Fu,&nbsp;Jian-Ming Pei,&nbsp;Sergey V Logvinov","doi":"10.7555/JBR.36.20220123","DOIUrl":"https://doi.org/10.7555/JBR.36.20220123","url":null,"abstract":"<p><p>Acute myocardial infarction (AMI) is one of the main reasons of cardiovascular disease-related death. The introduction of percutaneous coronary intervention to clinical practice dramatically decreased the mortality rate in AMI. Adverse cardiac remodeling is a serious problem in cardiology. An increase in the effectiveness of AMI treatment and prevention of adverse cardiac remodeling is difficult to achieve without understanding the mechanisms of reperfusion cardiac injury and cardiac remodeling. Inhibition of pyroptosis prevents the development of postinfarction and pressure overload-induced cardiac remodeling, and mitigates cardiomyopathy induced by diabetes and metabolic syndrome. Therefore, it is reasonable to hypothesize that the pyroptosis inhibitors may find a role in clinical practice for treatment of AMI and prevention of cardiac remodeling, diabetes and metabolic syndrome-triggered cardiomyopathy. It was demonstrated that pyroptosis interacts closely with apoptosis and autophagy. Pyroptosis could be inhibited by nucleotide-binding oligomerization domain-like receptor with a pyrin domain 3 inhibitors, caspase-1 inhibitors, microRNA, angiotensin-converting enzyme inhibitors, angiotensin Ⅱ receptor blockers, and traditional Chinese herbal medicines.</p>","PeriodicalId":15061,"journal":{"name":"Journal of Biomedical Research","volume":"36 6","pages":"375-389"},"PeriodicalIF":2.3,"publicationDate":"2022-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10529077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The new antioxidant 1-benzoyl-6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline has a protective effect against carbon tetrachloride-induced hepatic injury in rats. 新型抗氧化剂1-苯甲酰-6-羟基-2,2,4-三甲基-1,2-二氢喹啉对四氯化碳诱导的大鼠肝损伤具有保护作用。
IF 2.3 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-07-28 DOI: 10.7555/JBR.36.20220098
Evgenii Dmitrievich Kryl'skii, Darya Andreevna Sinitsyna, Tatyana Nikolaevna Popova, Khidmet Safarovich Shikhaliev, Svetlana Mikhajlovna Medvedeva, Larisa Vladimirovna Matasova, Valentina Olegovna Mittova

Liver diseases with the central pathogenetic mechanism of oxidative stress are one of the main causes of mortality worldwide. Therefore, dihydroquinoline derivatives, which are precursors of hepatoprotectors and have antioxidant activity, are of interest. We have previously found that some compounds in this class have the ability to normalize redox homeostasis under experimental conditions. Here, we initially analyzed the hepatoprotective potential of the dihydroquinoline derivative 1-benzoyl-6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline (BHDQ) for carbon tetrachloride (CCl 4)-induced liver injury in rats. Results suggested that BHDQ normalized the alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transpeptidase in serum. We also observed an improvement in liver tissue morphology related to BHDQ. Animals with CCl 4-induced liver injuries treated with BHDQ had less oxidative stress compared to animals with CCl 4-induced liver injury. BHDQ promoted activation changes in superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, and glutathione transferase on control values in animals with CCl 4-induced liver injury. BHDQ also activated gene transcription in Sod1 and Gpx1 via nuclear factor erythroid 2-related factor 2 and forkhead box protein O1 factors. Therefore, the compound of concern has a hepatoprotective effect by inhibiting the development of necrotic processes in the liver tissue, through antioxidation.

以氧化应激为中心发病机制的肝脏疾病是世界范围内导致死亡的主要原因之一。因此,作为肝保护剂前体和具有抗氧化活性的二氢喹啉衍生物引起了人们的兴趣。我们之前已经发现,这类化合物中的一些在实验条件下具有使氧化还原稳态正常化的能力。在这里,我们初步分析了二氢喹啉衍生物1-苯甲酰-6-羟基-2,2,4-三甲基-1,2-二氢喹啉(BHDQ)对四氯化碳(CCl 4)诱导的大鼠肝损伤的保护作用。结果表明,BHDQ能使血清丙氨酸转氨酶、天冬氨酸转氨酶和γ -谷氨酰转肽酶恢复正常。我们还观察到与BHDQ相关的肝组织形态学的改善。与cc4肝损伤动物相比,BHDQ处理cc4肝损伤动物的氧化应激较低。BHDQ可促进CCl - 4肝损伤动物超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化物酶、谷胱甘肽还原酶和谷胱甘肽转移酶的活性变化。BHDQ还通过核因子红系2相关因子2和叉头盒蛋白O1因子激活Sod1和Gpx1基因转录。因此,所关注的化合物通过抗氧化抑制肝组织坏死过程的发展,具有保护肝脏的作用。
{"title":"The new antioxidant 1-benzoyl-6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline has a protective effect against carbon tetrachloride-induced hepatic injury in rats.","authors":"Evgenii Dmitrievich Kryl'skii,&nbsp;Darya Andreevna Sinitsyna,&nbsp;Tatyana Nikolaevna Popova,&nbsp;Khidmet Safarovich Shikhaliev,&nbsp;Svetlana Mikhajlovna Medvedeva,&nbsp;Larisa Vladimirovna Matasova,&nbsp;Valentina Olegovna Mittova","doi":"10.7555/JBR.36.20220098","DOIUrl":"https://doi.org/10.7555/JBR.36.20220098","url":null,"abstract":"<p><p>Liver diseases with the central pathogenetic mechanism of oxidative stress are one of the main causes of mortality worldwide. Therefore, dihydroquinoline derivatives, which are precursors of hepatoprotectors and have antioxidant activity, are of interest. We have previously found that some compounds in this class have the ability to normalize redox homeostasis under experimental conditions. Here, we initially analyzed the hepatoprotective potential of the dihydroquinoline derivative 1-benzoyl-6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline (BHDQ) for carbon tetrachloride (CCl <sub>4</sub>)-induced liver injury in rats. Results suggested that BHDQ normalized the alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transpeptidase in serum. We also observed an improvement in liver tissue morphology related to BHDQ. Animals with CCl <sub>4</sub>-induced liver injuries treated with BHDQ had less oxidative stress compared to animals with CCl <sub>4</sub>-induced liver injury. BHDQ promoted activation changes in superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, and glutathione transferase on control values in animals with CCl <sub>4</sub>-induced liver injury. BHDQ also activated gene transcription in <i>Sod1</i> and <i>Gpx1</i> <i>via</i> nuclear factor erythroid 2-related factor 2 and forkhead box protein O1 factors. Therefore, the compound of concern has a hepatoprotective effect by inhibiting the development of necrotic processes in the liver tissue, through antioxidation.</p>","PeriodicalId":15061,"journal":{"name":"Journal of Biomedical Research","volume":"36 6","pages":"423-434"},"PeriodicalIF":2.3,"publicationDate":"2022-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10529078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Acquired immunity and Alzheimer's disease. 获得性免疫和阿尔茨海默病
IF 2.3 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-07-28 DOI: 10.7555/JBR.36.20220083
Weixi Feng, Yanli Zhang, Peng Sun, Ming Xiao

Alzheimer's disease (AD) is an age-related neurodegenerative disease characterized by progressive cognitive defects. The role of the central immune system dominated by microglia in the progression of AD has been extensively investigated. However, little is known about the peripheral immune system in AD pathogenesis. Recently, with the discovery of the meningeal lymphatic vessels and glymphatic system, the roles of the acquired immunity in the maintenance of central homeostasis and neurodegenerative diseases have attracted an increasing attention. The T cells not only regulate the function of neurons, astrocytes, microglia, oligodendrocytes and brain microvascular endothelial cells, but also participate in the clearance of β-amyloid (Aβ) plaques. Apart from producing antibodies to bind Aβ peptides, the B cells affect Aβ-related cascades via a variety of antibody-independent mechanisms. This review systemically summarizes the recent progress in understanding pathophysiological roles of the T cells and B cells in AD.

阿尔茨海默病(AD)是一种以进行性认知缺陷为特征的与年龄相关的神经退行性疾病。以小胶质细胞为主导的中枢免疫系统在阿尔茨海默病进展中的作用已被广泛研究。然而,对AD发病机制中的外周免疫系统知之甚少。近年来,随着脑膜淋巴管和淋巴系统的发现,获得性免疫在中枢稳态维持和神经退行性疾病中的作用越来越受到人们的关注。T细胞不仅调节神经元、星形胶质细胞、小胶质细胞、少突胶质细胞和脑微血管内皮细胞的功能,还参与β-淀粉样蛋白(Aβ)斑块的清除。除了产生结合a β肽的抗体外,B细胞还通过多种不依赖抗体的机制影响a β相关级联反应。本文系统综述了近年来对T细胞和B细胞在AD中的病理生理作用的研究进展。
{"title":"Acquired immunity and Alzheimer's disease.","authors":"Weixi Feng,&nbsp;Yanli Zhang,&nbsp;Peng Sun,&nbsp;Ming Xiao","doi":"10.7555/JBR.36.20220083","DOIUrl":"https://doi.org/10.7555/JBR.36.20220083","url":null,"abstract":"<p><p>Alzheimer's disease (AD) is an age-related neurodegenerative disease characterized by progressive cognitive defects. The role of the central immune system dominated by microglia in the progression of AD has been extensively investigated. However, little is known about the peripheral immune system in AD pathogenesis. Recently, with the discovery of the meningeal lymphatic vessels and glymphatic system, the roles of the acquired immunity in the maintenance of central homeostasis and neurodegenerative diseases have attracted an increasing attention. The T cells not only regulate the function of neurons, astrocytes, microglia, oligodendrocytes and brain microvascular endothelial cells, but also participate in the clearance of β-amyloid (Aβ) plaques. Apart from producing antibodies to bind Aβ peptides, the B cells affect Aβ-related cascades <i>via</i> a variety of antibody-independent mechanisms. This review systemically summarizes the recent progress in understanding pathophysiological roles of the T cells and B cells in AD.</p>","PeriodicalId":15061,"journal":{"name":"Journal of Biomedical Research","volume":"37 1","pages":"15-29"},"PeriodicalIF":2.3,"publicationDate":"2022-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10681965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticoagulation therapy for pulmonary embolism involving a myxoma mimicking, giant type C thrombus: A case report. 肺栓塞伴黏液瘤样巨大C型血栓的抗凝治疗1例。
IF 2.3 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-07-28 DOI: 10.7555/JBR.36.20220118
Yinhe Feng, Yubin Wang, Xiaolong Li, Hui Mao

Right heart thrombus (RHTh) with concurrent acute pulmonary embolism (PE) is rare and can seriously destabilize hemodynamics, leading to an emergency situation with high mortality. Diagnosis and treatment of RHTh with acute PE are not yet standardized. There are few reports of acute PE concurrent with RHTh and even less is known about patients with a right heart mural thrombus. For physicians, the diagnostic choice and treatment of these patients are particularly difficult due to the lack of knowledge. Here, we report a rare case of partial mural RHTh (type C RHTh) with acute PE. The mural mass in the right heart was initially diagnosed as atrial myxoma according to transthoracic echocardiography (TTE), and both pulmonary embolus and the mural mass were completely absorbed after administering Rivaroxiban. This case suggests that TTE alone is insufficient to identify and diagnoses a right heart mural mass such as this. However, novel oral anticoagulants may be effective at alleviating PE with type C RHTh.

右心血栓(RHTh)并发急性肺栓塞(PE)是罕见的,可严重破坏血流动力学,导致高死亡率的紧急情况。RHTh合并急性PE的诊断和治疗尚未标准化。急性PE合并RHTh的报道很少,对右心壁血栓患者的报道就更少了。对于医生来说,由于缺乏相关知识,对这些患者的诊断选择和治疗尤其困难。在此,我们报告一例罕见的局部壁性RHTh (C型RHTh)伴急性PE。经胸超声心动图(TTE)初步诊断右心附壁肿块为心房黏液瘤,给予利伐昔班后肺栓塞及附壁肿块均完全吸收。本病例提示单靠TTE不足以识别和诊断右心壁肿块。然而,新型口服抗凝剂可能对缓解C型RHTh合并PE有效。
{"title":"Anticoagulation therapy for pulmonary embolism involving a myxoma mimicking, giant type C thrombus: A case report.","authors":"Yinhe Feng,&nbsp;Yubin Wang,&nbsp;Xiaolong Li,&nbsp;Hui Mao","doi":"10.7555/JBR.36.20220118","DOIUrl":"https://doi.org/10.7555/JBR.36.20220118","url":null,"abstract":"<p><p>Right heart thrombus (RHTh) with concurrent acute pulmonary embolism (PE) is rare and can seriously destabilize hemodynamics, leading to an emergency situation with high mortality. Diagnosis and treatment of RHTh with acute PE are not yet standardized. There are few reports of acute PE concurrent with RHTh and even less is known about patients with a right heart mural thrombus. For physicians, the diagnostic choice and treatment of these patients are particularly difficult due to the lack of knowledge. Here, we report a rare case of partial mural RHTh (type C RHTh) with acute PE. The mural mass in the right heart was initially diagnosed as atrial myxoma according to transthoracic echocardiography (TTE), and both pulmonary embolus and the mural mass were completely absorbed after administering Rivaroxiban. This case suggests that TTE alone is insufficient to identify and diagnoses a right heart mural mass such as this. However, novel oral anticoagulants may be effective at alleviating PE with type C RHTh.</p>","PeriodicalId":15061,"journal":{"name":"Journal of Biomedical Research","volume":"37 2","pages":"148-152"},"PeriodicalIF":2.3,"publicationDate":"2022-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9516857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SIRT3 regulates mitochondrial biogenesis in aging-related diseases. SIRT3调控衰老相关疾病的线粒体生物发生。
IF 2.3 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-06-28 DOI: 10.7555/JBR.36.20220078
Hong-Yan Li, Zhi-You Cai

Sirtuin 3 (SIRT3), the main family member of mitochondrial deacetylase, targets the majority of substrates controlling mitochondrial biogenesis via lysine deacetylation and modulates important cellular functions such as energy metabolism, reactive oxygen species production and clearance, oxidative stress, and aging. Deletion of SIRT3 has a deleterious effect on mitochondrial biogenesis, thus leading to the defect in mitochondrial function and insufficient ATP production. Imbalance of mitochondrial dynamics leads to excessive mitochondrial biogenesis, dampening mitochondrial function. Mitochondrial dysfunction plays an important role in several diseases related to aging, such as cardiovascular disease, cancer and neurodegenerative diseases. Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) launches mitochondrial biogenesis through activating nuclear respiratory factors. These factors act on genes, transcribing and translating mitochondrial DNA to generate new mitochondria. PGC1α builds a bridge between SIRT3 and mitochondrial biogenesis. This review described the involvement of SIRT3 and mitochondrial dynamics, particularly mitochondrial biogenesis in aging-related diseases, and further illustrated the role of the signaling events between SIRT3 and mitochondrial biogenesis in the pathological process of aging-related diseases.

Sirtuin 3 (SIRT3)是线粒体去乙酰化酶的主要家族成员,通过赖氨酸去乙酰化作用作用于控制线粒体生物发生的大多数底物,并调节重要的细胞功能,如能量代谢、活性氧的产生和清除、氧化应激和衰老。SIRT3的缺失对线粒体生物发生有有害影响,从而导致线粒体功能缺陷和ATP产生不足。线粒体动力学失衡导致线粒体生物生成过度,抑制线粒体功能。线粒体功能障碍在心血管疾病、癌症和神经退行性疾病等与衰老相关的疾病中起着重要作用。过氧化物酶体增殖物激活受体γ辅助激活因子1- α (PGC1α)通过激活核呼吸因子启动线粒体生物发生。这些因子作用于基因,转录和翻译线粒体DNA以产生新的线粒体。PGC1α在SIRT3和线粒体生物发生之间建立了一座桥梁。本文综述了SIRT3与线粒体动力学,特别是线粒体生物发生在衰老相关疾病中的作用,并进一步阐明了SIRT3与线粒体生物发生之间的信号事件在衰老相关疾病病理过程中的作用。
{"title":"SIRT3 regulates mitochondrial biogenesis in aging-related diseases.","authors":"Hong-Yan Li,&nbsp;Zhi-You Cai","doi":"10.7555/JBR.36.20220078","DOIUrl":"https://doi.org/10.7555/JBR.36.20220078","url":null,"abstract":"<p><p>Sirtuin 3 (SIRT3), the main family member of mitochondrial deacetylase, targets the majority of substrates controlling mitochondrial biogenesis <i>via</i> lysine deacetylation and modulates important cellular functions such as energy metabolism, reactive oxygen species production and clearance, oxidative stress, and aging. Deletion of <i>SIRT3</i> has a deleterious effect on mitochondrial biogenesis, thus leading to the defect in mitochondrial function and insufficient ATP production. Imbalance of mitochondrial dynamics leads to excessive mitochondrial biogenesis, dampening mitochondrial function. Mitochondrial dysfunction plays an important role in several diseases related to aging, such as cardiovascular disease, cancer and neurodegenerative diseases. Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) launches mitochondrial biogenesis through activating nuclear respiratory factors. These factors act on genes, transcribing and translating mitochondrial DNA to generate new mitochondria. PGC1α builds a bridge between SIRT3 and mitochondrial biogenesis. This review described the involvement of SIRT3 and mitochondrial dynamics, particularly mitochondrial biogenesis in aging-related diseases, and further illustrated the role of the signaling events between SIRT3 and mitochondrial biogenesis in the pathological process of aging-related diseases.</p>","PeriodicalId":15061,"journal":{"name":"Journal of Biomedical Research","volume":"37 2","pages":"77-88"},"PeriodicalIF":2.3,"publicationDate":"2022-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9513836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Washed microbiota transplantation stopped the deterioration of amyotrophic lateral sclerosis: The first case report and narrative review. 水洗菌群移植阻止肌萎缩性侧索硬化症恶化:第一例报告及叙述回顾。
IF 2.3 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-06-28 DOI: 10.7555/JBR.36.20220088
Gaochen Lu, Quan Wen, Bota Cui, Qianqian Li, Faming Zhang

Amyotrophic lateral sclerosis (ALS) is known as a progressive paralysis disorder characterized by degeneration of upper and lower motor neurons, and has an average survival time of three to five years. Growing evidence has suggested a bidirectional link between gut microbiota and neurodegeneration. Here we aimed to report one female case with ALS, who benefited from washed microbiota transplantation (WMT), an improved fecal microbiota transplantation (FMT), through a transendoscopic enteral tube during a 12-month follow-up. Notedly, the accidental scalp trauma the patient suffered later was treated with prescribed antibiotics that caused ALS deterioration. The subsequent rescue WMTs successfully stopped the progression of the disease with a quick improvement. The plateaus and reversals occurred during the whole course of WMT. The stool and blood samples from the first WMT to the last were collected for dynamic microbial and metabolomic analysis. We observed the microbial and metabolomic changing trend consistent with the disease status. This case report for the first time shows the direct clinical evidence on using WMT for treating ALS, indicating that WMT may be the novel treatment strategy for controlling this so-called incurable disease.

肌萎缩性侧索硬化症(ALS)是一种以上下运动神经元退化为特征的进行性瘫痪疾病,平均生存时间为3至5年。越来越多的证据表明,肠道微生物群与神经变性之间存在双向联系。在这里,我们的目的是报告一名女性ALS患者,在12个月的随访中,她通过经内镜肠内管接受了洗涤微生物群移植(WMT),一种改进的粪便微生物群移植(FMT)。值得注意的是,患者后来遭受的意外头皮创伤是用处方抗生素治疗的,导致ALS恶化。随后的救援wmt成功地阻止了疾病的进展,病情迅速好转。高原和逆转发生在整个WMT过程中。从第一次分娩到最后一次分娩,收集粪便和血液样本进行动态微生物和代谢组学分析。我们观察到微生物和代谢组学的变化趋势与疾病状况一致。本病例报告首次提供了WMT治疗ALS的直接临床证据,提示WMT可能是控制这一所谓不治之症的新治疗策略。
{"title":"Washed microbiota transplantation stopped the deterioration of amyotrophic lateral sclerosis: The first case report and narrative review.","authors":"Gaochen Lu,&nbsp;Quan Wen,&nbsp;Bota Cui,&nbsp;Qianqian Li,&nbsp;Faming Zhang","doi":"10.7555/JBR.36.20220088","DOIUrl":"https://doi.org/10.7555/JBR.36.20220088","url":null,"abstract":"<p><p>Amyotrophic lateral sclerosis (ALS) is known as a progressive paralysis disorder characterized by degeneration of upper and lower motor neurons, and has an average survival time of three to five years. Growing evidence has suggested a bidirectional link between gut microbiota and neurodegeneration. Here we aimed to report one female case with ALS, who benefited from washed microbiota transplantation (WMT), an improved fecal microbiota transplantation (FMT), through a transendoscopic enteral tube during a 12-month follow-up. Notedly, the accidental scalp trauma the patient suffered later was treated with prescribed antibiotics that caused ALS deterioration. The subsequent rescue WMTs successfully stopped the progression of the disease with a quick improvement. The plateaus and reversals occurred during the whole course of WMT. The stool and blood samples from the first WMT to the last were collected for dynamic microbial and metabolomic analysis. We observed the microbial and metabolomic changing trend consistent with the disease status. This case report for the first time shows the direct clinical evidence on using WMT for treating ALS, indicating that WMT may be the novel treatment strategy for controlling this so-called incurable disease.</p>","PeriodicalId":15061,"journal":{"name":"Journal of Biomedical Research","volume":"37 1","pages":"69-76"},"PeriodicalIF":2.3,"publicationDate":"2022-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10738351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Medical image translation using an edge-guided generative adversarial network with global-to-local feature fusion. 基于全局到局部特征融合的边缘导向生成对抗网络医学图像翻译。
IF 2.3 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-06-28 DOI: 10.7555/JBR.36.20220037
Hamed Amini Amirkolaee, Hamid Amini Amirkolaee

In this paper, we propose a framework based deep learning for medical image translation using paired and unpaired training data. Initially, a deep neural network with an encoder-decoder structure is proposed for image-to-image translation using paired training data. A multi-scale context aggregation approach is then used to extract various features from different levels of encoding, which are used during the corresponding network decoding stage. At this point, we further propose an edge-guided generative adversarial network for image-to-image translation based on unpaired training data. An edge constraint loss function is used to improve network performance in tissue boundaries. To analyze framework performance, we conducted five different medical image translation tasks. The assessment demonstrates that the proposed deep learning framework brings significant improvement beyond state-of-the-arts.

在本文中,我们提出了一种基于深度学习的框架,用于使用成对和非成对训练数据进行医学图像翻译。首先,提出了一种具有编码器-解码器结构的深度神经网络,用于使用成对训练数据进行图像到图像的翻译。然后使用多尺度上下文聚合方法从不同层次的编码中提取各种特征,并在相应的网络解码阶段使用这些特征。在这一点上,我们进一步提出了一种基于未配对训练数据的边缘引导生成对抗网络用于图像到图像的翻译。利用边缘约束损失函数提高网络在组织边界处的性能。为了分析框架的性能,我们进行了五种不同的医学图像翻译任务。评估表明,所提出的深度学习框架带来了超越最先进水平的重大改进。
{"title":"Medical image translation using an edge-guided generative adversarial network with global-to-local feature fusion.","authors":"Hamed Amini Amirkolaee,&nbsp;Hamid Amini Amirkolaee","doi":"10.7555/JBR.36.20220037","DOIUrl":"https://doi.org/10.7555/JBR.36.20220037","url":null,"abstract":"<p><p>In this paper, we propose a framework based deep learning for medical image translation using paired and unpaired training data. Initially, a deep neural network with an encoder-decoder structure is proposed for image-to-image translation using paired training data. A multi-scale context aggregation approach is then used to extract various features from different levels of encoding, which are used during the corresponding network decoding stage. At this point, we further propose an edge-guided generative adversarial network for image-to-image translation based on unpaired training data. An edge constraint loss function is used to improve network performance in tissue boundaries. To analyze framework performance, we conducted five different medical image translation tasks. The assessment demonstrates that the proposed deep learning framework brings significant improvement beyond state-of-the-arts.</p>","PeriodicalId":15061,"journal":{"name":"Journal of Biomedical Research","volume":"36 6","pages":"409-422"},"PeriodicalIF":2.3,"publicationDate":"2022-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724158/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10582932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Journal of Biomedical Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1